Concepedia

Kristine A. Gordon

KA

15

Publications

2.3K

Citations

15

H-Index

2003

Active since

Affiliations

Seagen (United States)(Current)

The University of Texas MD Anderson Cancer Center

Vrije Universiteit Amsterdam

Molecular Oncology (United States)

Kristine A. Gordon is an author at Seagen (United States) specializing in immunotherapy, medicine, and immunology.

Top concepts

Publications per year

2003–2017

15

Publications

15

cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity

Joseph A. Francisco, Charles G. Cerveny, Damon L. Meyer et al. · Blood · 2003 · 907 citations

Lysosomal Trafficking and Cysteine Protease Metabolism Confer Target-specific Cytotoxicity by Peptide-linked Anti-CD30-Auristatin Conjugates

May S.K. Sutherland, Russell J. Sanderson, Kristine A. Gordon et al. · Journal of Biological Chemistry · 2006 · 291 citations · Full text

Lymphocyte Activation Antigen CD70 Expressed by Renal Cell Carcinoma Is a Potential Therapeutic Target for Anti-CD70 Antibody-Drug Conjugates

Che-Leung Law, Kristine A. Gordon, Brian E. Toki et al. · Cancer Research · 2006 · 150 citations

, , +16

Preclinical Antilymphoma Activity of a Humanized Anti-CD40 Monoclonal Antibody, SGN-40

Che‐Leung Law, Kristine A. Gordon, J.M. Collier et al. · Cancer Research · 2005 · 124 citations · Full text

, , +18

Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30

Ezogelin Oflazoglu, Ivan J. Stone, Kristine A. Gordon et al. · Blood · 2007 · 117 citations · Full text

Rows per page

1–5 of 15